|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3984528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21194622.3 |
| Date of filing the European patent application | 2007-09-25 | |
| (97) | Date of publication of the European application | 2022-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-05 |
| (46) | Date of publication of the claims translation | 2023-08-10 |
| (30) | Number | Date | Country code |
| 06121371 | 2006-09-27 | EP |
| (72) |
Bruneau, Nathalie , FR
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė kompozicija, apimanti nilotinibą |
| PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB |
| Payment date | Validity (years) | Amount | |
| 2024-08-22 | 18 | 347.00 EUR |
| 2025-09-25 |